<DOC>
	<DOCNO>NCT01428193</DOCNO>
	<brief_summary>The purpose study understand effect elevate male hormone adolescent girl effect development polycystic ovary syndrome ( PCOS ) . If investigator understand effect elevate male hormone level girl , investigator may able good treat girl elevate male hormone level perhaps even learn prevent development PCOS . Females elevate level male hormone respond differently estrace ( estradiol ) progesterone females normal male hormone level . The investigator give estrogen progesterone see respond male hormone block medication call flutamide .</brief_summary>
	<brief_title>Effects Androgen Blockade Sensitivity GnRH Pulse Generator Suppression Estradiol Progesterone</brief_title>
	<detailed_description>Similar woman PCOS , girls hyperandrogenemia increase frequency LH pulse compare age match control . An ongoing study group investigate whether progesterone insensitivity GnRH pulse generator adult woman PCOS also see adolescent girl hyperandrogenemia . Analysis data date suggest hyperandrogenic adolescent girl decrease hypothalamic progesterone sensitivity compare adolescent control , subgroup ( consist approximately half hyperandrogenic girl ) mark progesterone insensitivity similar see adult woman PCOS . These data recently publish . Given androgen mediate hypothalamic progesterone insensitivity adult woman PCOS , hypothesize androgen play similar role adolescent girl hyperandrogenemia progesterone sensitivity restore use androgen receptor blocker flutamide . Better understanding effect hyperandrogenemia adolescence role development PCOS hopefully lead improved prevention treatment strategy PCOS . This may prove increasingly important current epidemic childhood obesity result grow number girl elevate androgen level .</detailed_description>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Hyperandrogenism</mesh_term>
	<mesh_term>Flutamide</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Girls age 13 17 Tanner IV V stage puberty Postmenarche Hyperandrogenemic ( total testosterone &gt; 0.4 ng/mL free testosterone &gt; 35 pmol/L ) without hirsutism Normal aspartate aminotransferase/alanine aminotransferase ( AST/ALT ) ( AST &lt; 35 U/L , ALT &lt; 55 U/L ) Hemoglobin &gt; 12 mg/dL Hematocrit &gt; 36 % Normal screening lab ( exception expect hormonal abnormality inherent hyperandrogenemia ) Sexually active subject must agree abstain use double barrier contraception study Subjects must agree take medication course study without approval study investigator Abnormal screen lab ( exception expect hormonal abnormality inherent hyperandrogenemia ) Elevated AST/ALT ( AST &gt; 35 U/L , ALT &gt; 55 U/L ) Hemoglobin &lt; 12 mg/dL hematocrit &lt; 36 % Weight &lt; 32 kg History liver disease , peanut allergy , deep venous thrombosis , breast cancer , endometrial cancer , cervical cancer Pregnant breastfeeding On medication know affect reproductive axis within 3 month study ( include oral contraceptive pill , metformin , spironolactone ) On medication know likely inhibit induce CYP1A2 CYP3A4 ( please see `` Restrictions use drug treatment '' section common example drug ) Are currently participate another study one last 30 day .</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>PCOS</keyword>
	<keyword>hyperandrogenemia</keyword>
</DOC>